Dr Knight on the Investigation of Patients With Brain-Metastatic Prostate Adenocarcinoma

Commentary
Video
Conference|ACRO Summit

James Knight, MD, discusses the potential launch of a case series of patients with brain-metastatic prostate adenocarcinoma.

James Knight, MD, resident, Radiation Medicine, the University of Kentucky College of Medicine, discusses the potential launch of a case series of patients with brain-metastatic prostate adenocarcinoma, highlighting the importance of the continued research regarding additional biomarkers which may improve the treatment landscape.

Related Videos
Scott Kopetz, MD, PhD, FACP
Gottfried Konecny, MD
Akriti Jain, MD
Ibrahim Aldoss, MD
Rita Nanda, MD
Kenneth C. Anderson, MD
Keiichi Fujiwara, MD, PhD, Saitama Medical University International Medical Center
Nikhil A. Gopal, MD
Kara N. Maxwell, MD, PhD
Ruben Olivares, MD
Related Content
Rohan Garje, MD, Miami Cancer Institute

Garje Elucidates Biomarker-Driven Approaches Generating Excitement in Metastatic Prostate Cancer

April 26th 2024
Article
Neeraj Agarwal, MD

FDA Approval Insights: Talazoparib Plus Enzalutamide in HRR Gene–Mutated mCRPC

July 17th 2023
Podcast
Antonio Alcaraz, PhD, chairman, Department of Urology, University Hospital Clinic of Barcelona

Enzalutamide Receives Go Ahead From European Commission in nmHSPC

April 24th 2024
Article
Andrew J. Armstrong, MD, MSc

FDA Approval Insights: Olaparib Plus Abiraterone in BRCA-Mutated mCRPC

June 15th 2023
Podcast
Idalid Franco, MD, MPH, director of Equity Access and Inclusion in the Department of Radiation Oncology at Brigham and Women’s Hospital and an instructor at Harvard Medical School, both in Boston, Massachusetts

Navigating the Intersection of Radiation Therapy and Immunotherapy in Endometrial Cancer

April 20th 2024
Article
OncLive On Air

Revisit Every OncLive On Air Episode from March 2024

April 19th 2024
Article